Observational Study on Intubation Induction Agents in Critically Ill Patients

This study is looking back at medical records of critically ill adult patients who needed a breathing tube (tracheal intubation) in the surgical intensive care unit (ICU). Researchers want to understand if the choice of medicine used to help patients relax for intubation, like Propofol, affects how well they do. They are specifically looking at how many patients pass away within 7 days after intubation. You could be included if you are 18 or older, were admitted to the surgical ICU, received one of the studied induction agents, and have complete medical records. This is an observational study, meaning researchers are just reviewing existing information, not giving new treatments. The study aims to enroll 4 participants, but its current status is unclear.

Study design
This is an observational study, meaning researchers are looking back at existing medical records. It is not a clinical trial where new treatments are given.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Researchers will look at outcomes for 7 days following tracheal intubation.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07222007

Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients

Recruiting
Not specifiedAges 18+Observational
Zeliha Alicikus
~4 participants
Updated 2026-04-14 on ClinicalTrials.gov
What's tested:induction type for intubation in ICU

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Primary Outcome will be all-cause mortality at day 7 following tracheal intubation
Measured over day 7
Critically Ill
Intubation Complication
Oxygenation
Airway Management
Propofol
Ketamine
1 sites across 1 states
Florida1
  • TOLGA SARAÇOĞLU, Prof,MD · PRINCIPAL_INVESTIGATOR · Florida University Jacksonville

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥ 18 years
Admission to the surgical ICU for critical care
Administration of one of the studied induction agents
Availability of complete clinical data

Exclusion

Age \< 18 years
Absence of documented induction agent administration
Incomplete or missing medical records
  • Primary Outcome will be all-cause mortality at day 7 following tracheal intubationday 7

    mortality at day 7